Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07791836 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study

Name: Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study — clinical trial record (NCT07791836)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot specified

SponsorAryoGen Pharmed Co.

Started2026-08-23

View on ClinicalTrials.gov ↗

This is a cross-sectional, observational, multi-center study to assess the prevalence of inhibitor development in hemophilia A patients receiving Coageight (rFVIII-Fc, AryoGen Pharmed Co.).

Trial Details

NCT Number	NCT07791836
Lead Sponsor	AryoGen Pharmed Co.
Conditions	Hemophilia A, Hemophilia
Enrollment	262 participants
Start Date	2026-08-23
Primary Completion	2027-02-20 (estimated)
Study Completion	2027-02-20 (estimated)
Updated on ClinicalTrials.gov	2026-08-28